Table 1.
Of All 69 Patients with 133 Liver Tumors, Patients' Characteristics, Locations of Primary Lesions and Liver Tumors, Size of Liver Tumors, Diagnosis of Liver Tumors, Methods of Final Diagnosis of Liver Tumors, and Interval Between Performances of Contrast‐Enhanced Ultrasonography (CEUS) and Gd‐EOB‐DTPA‐enhanced MRI (EOB‐MRI)
| Characteristics | All (n = 69) |
|---|---|
| Age (years) (mean ± SD) | 66 ± 12 |
| Gender | |
| Male/female | 46/23 |
| Locations of primary lesions | |
| Rectum | 27 |
| Sigmoid colon | 22 |
| Descending colon | 0 |
| Transverse colon | 10 |
| Ascending colon | 8 |
| Cecum | 2 |
| Liver tumors | 133 |
| Liver metastases/others | 109/24 |
| Others | |
| Hepatic hemangioma | 11 |
| Liver cyst | 9 |
| Hepatocellular carcinoma | 2 |
| Bile duct adenoma | 1 |
| Necrosis after treatment | 1 |
| Tumor size (mm) (mean ± SD) | 21.3 ± 17.9 |
| Locations of liver tumors (Couinaud's segment) | |
| S1 | 2 |
| S2 | 7 |
| S3 | 11 |
| S4 | 23 |
| S5 | 14 |
| S6 | 25 |
| S7 | 20 |
| S8 | 31 |
| Final definite diagnosis | |
| Histopathological examination | 61 |
| Various imaging modalities | 72 |
| Interval between performance of CEUS and EOB‐MRI (days) (mean ± SD) | 11 ± 12.5 |
Abbreviations: CEUS, contrast‐enhanced ultrasonography; EOB‐MRI: Gd‐EOB‐DTPA enhanced‐MRI.